Loading clinical trials...
Loading clinical trials...
Development of an Oral Prime-Boost AIDS Vaccine to Elicit Broadly Neutralizing Antibodies Against HIV-1
Conditions
Interventions
SCBaL/M9
Locations
1
United States
Institute of Human Virology
Baltimore, Maryland, United States
Last Updated
September 26, 2008
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions